Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
leuprorelin + follitropin alfa
- Development stage
- Unknown
- Lead developer
- Merck KGaA
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Subcutaneous, Intramuscular
01
Overview
Leuprorelin + follitropin alfa is a combination of two injectable hormonal agents used primarily in assisted reproductive technology protocols, such as in vitro fertilization (IVF). Leuprorelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist that initially stimulates, then suppresses, the pituitary release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to downregulation of endogenous gonadotropins. Follitropin alfa is a recombinant form of human FSH that directly stimulates ovarian follicular development. The combination allows for controlled ovarian hyperstimulation by first suppressing natural cycles with leuprorelin and then stimulating follicle growth with exogenous FSH from follitropin alfa[1][2][4][6][7].
- Brand names
- Lupron
- Other names
- leuprolide
02
Targets
FSHR (Follicle-stimulating hormone receptor)GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on leuprorelin + follitropin alfa.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on leuprorelin + follitropin alfa.